CytoDyn Inc.
OTC:CYDY
0.18 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.266 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.006 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.029 | 0.175 | 0.053 | 1.797 | 2.034 | 1.245 | 0.356 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.029 | -0.175 | 0.213 | -1.797 | -2.034 | -1.245 | -0.356 | -0.366 | -0.362 | 0 | 0 | 0 | -0.026 | 0.006 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.801 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 7.24 | 2.632 | 27.043 | 53.403 | 52.64 | 42.49 | 38.223 | 20.206 | 13.731 | 15.156 | 3.981 | 0.62 | 0.53 | 0.481 | 0.329 | 0.469 | 0.164 | 0.425 | 0 | 0.362 | 0 |
| General & Administrative Expenses
| 10.789 | 17.136 | 44.303 | 34.32 | 19.973 | 12.117 | 7.341 | 6.76 | 7.082 | 4.08 | 3.779 | 7.151 | 6.924 | 3.215 | 3.343 | 1.391 | 1.063 | 1.872 | 1.178 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 17.119 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.789 | 17.136 | 44.303 | 34.32 | 19.973 | 12.117 | 7.341 | 6.76 | 7.082 | 4.08 | 3.779 | 7.151 | 6.924 | 3.215 | 3.301 | 1.391 | 1.063 | 1.872 | 1.178 | 0.411 | 0.357 |
| Other Expenses
| 0.029 | -20.633 | 74.271 | 1.797 | 2.034 | 1.245 | 0.356 | 0.366 | 0.362 | 0.361 | 0.352 | 0.223 | 0.002 | 0.692 | 0.044 | 0.009 | 0.002 | 0.168 | 0.002 | 0.002 | 0 |
| Operating Expenses
| 18.058 | 40.401 | 72.127 | 92.75 | 72.613 | 54.607 | 45.919 | 27.332 | 21.175 | 19.597 | 8.113 | 7.993 | 7.456 | 3.698 | 3.673 | 1.869 | 1.229 | 2.465 | 1.18 | 0.775 | 0.357 |
| Operating Income
| -18.058 | -40.576 | -145.404 | -104.596 | -74.647 | -55.852 | -45.919 | -27.331 | -21.176 | -19.597 | -8.113 | -7.993 | -7.456 | -3.698 | -3.673 | -1.869 | -1.229 | -2.465 | -1.18 | -0.775 | -0.357 |
| Operating Income Ratio
| 0 | 0 | -546.632 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -639.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -31.783 | -39.248 | -65.416 | -50.078 | -49.756 | -3.162 | -4.23 | 1.567 | -4.528 | -5.492 | -4.319 | -1.575 | -0.019 | -0.021 | -0.063 | 0.296 | 0.035 | -0.145 | -0.31 | -0.002 | -0 |
| Income Before Tax
| -49.841 | -79.824 | -210.82 | -154.674 | -124.403 | -59.014 | -50.15 | -25.764 | -25.704 | -25.088 | -12.431 | -9.568 | -7.474 | -3.72 | -3.737 | -1.573 | -1.194 | -2.61 | -1.49 | -0.777 | -0.358 |
| Income Before Tax Ratio
| 0 | 0 | -792.556 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -642.877 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 12.994 | 77.343 | 19.344 | 17.38 | -2.827 | -1.691 | -2.165 | -0.062 | 0.839 | 4.319 | 1.575 | 0.019 | 0.021 | 0.063 | 0.345 | 0.115 | 0.145 | 0.507 | 0.002 | 0 |
| Net Income
| -49.841 | -79.824 | -210.82 | -174.018 | -139.936 | -56.187 | -50.15 | -25.764 | -25.704 | -25.088 | -12.431 | -9.568 | -7.493 | -3.741 | -3.737 | -1.573 | -1.194 | -2.61 | -1.49 | -0.777 | -0.358 |
| Net Income Ratio
| 0 | 0 | -792.556 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -646.584 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.053 | -0.095 | -0.43 | -0.3 | -0.34 | -0.21 | -0.28 | -0.19 | -0.27 | -0.44 | -0.27 | -0.32 | -0.3 | -0.18 | -0.2 | -0.11 | -0.11 | -0.24 | -0.17 | -0.12 | -0.055 |
| EPS Diluted
| -0.053 | -0.095 | -0.43 | -0.3 | -0.34 | -0.21 | -0.28 | -0.19 | -0.27 | -0.44 | -0.27 | -0.32 | -0.3 | -0.18 | -0.2 | -0.11 | -0.11 | -0.24 | -0.17 | -0.12 | -0.055 |
| EBITDA
| -18.029 | -40.401 | -194.973 | -92.75 | 2.034 | -54.456 | -45.563 | -26.964 | -20.814 | -19.337 | -7.689 | -7.397 | 0.002 | 0.003 | 0.002 | -1.523 | -1.077 | -2.157 | -1.939 | -0.774 | -0.357 |
| EBITDA Ratio
| 0 | 0 | -732.981 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.498 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |